EZH2 and neoplasm: Patients whose tumors had greater than 10% or more tumor cells with positive nuclear staining for EZH2 had worse recurrence-free survival rates than did those with lower than 10% positively stained tumor cells, which is consistent with what has been observed by others (Fig. 2d–g) [24–26].